BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9726430)

  • 41. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
    Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Peters LE; Harned ME; Seroogy KB
    Ann N Y Acad Sci; 2006 Aug; 1074():272-81. PubMed ID: 17105923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus.
    Cheng H; Fu YS; Guo JW
    Hippocampus; 2004; 14(1):77-86. PubMed ID: 15058485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system.
    Nosrat IV; Smith CA; Mullally P; Olson L; Nosrat CA
    Eur J Neurosci; 2004 May; 19(9):2388-98. PubMed ID: 15128393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice.
    Chen LW; Zhang JP; Kwok-Yan Shum D; Chan YS
    J Comp Neurol; 2006 Aug; 497(6):898-909. PubMed ID: 16802332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons.
    Nakajima K; Hida H; Shimano Y; Fujimoto I; Hashitani T; Kumazaki M; Sakurai T; Nishino H
    Brain Res; 2001 Oct; 916(1-2):76-84. PubMed ID: 11597593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glial cell line-derived neurotrophic factor modulates ischemia-induced tyrosine hydroxylase expression in rat hippocampus.
    Miyazaki H; Ono T; Okuma Y; Nagashima K; Nomura Y
    Eur J Neurosci; 2000 Jun; 12(6):2032-8. PubMed ID: 10886342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity.
    Yurek DM; Fletcher-Turner A
    Brain Res; 1999 Oct; 845(1):21-7. PubMed ID: 10529440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum.
    Batchelor PE; Liberatore GT; Porritt MJ; Donnan GA; Howells DW
    Eur J Neurosci; 2000 Oct; 12(10):3462-8. PubMed ID: 11029615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation.
    Villadiego J; Méndez-Ferrer S; Valdés-Sánchez T; Silos-Santiago I; Fariñas I; López-Barneo J; Toledo-Aral JJ
    J Neurosci; 2005 Apr; 25(16):4091-8. PubMed ID: 15843611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets.
    Kholodilov N; Yarygina O; Oo TF; Zhang H; Sulzer D; Dauer W; Burke RE
    J Neurosci; 2004 Mar; 24(12):3136-46. PubMed ID: 15044553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrin alphav and NCAM mediate the effects of GDNF on DA neuron survival, outgrowth, DA turnover and motor activity in rats.
    Chao CC; Ma YL; Chu KY; Lee EH
    Neurobiol Aging; 2003; 24(1):105-16. PubMed ID: 12493556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Gudehithlu KP; Duchemin AM; Tejwani GA; Neff NH; Hadjiconstantinou M
    J Neurochem; 1991 Mar; 56(3):1043-8. PubMed ID: 1899692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy?
    Maruyama W; Naoi M
    J Neural Transm (Vienna); 2013 Jan; 120(1):83-9. PubMed ID: 22892822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells.
    Li XM; Juorio AV; Qi J; Boulton AA
    J Neurosci Res; 1998 Jul; 53(2):235-8. PubMed ID: 9671980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. l-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons.
    Xu L; Ma J; Seigel GM; Ma JX
    Biochem Pharmacol; 1999 Oct; 58(7):1183-90. PubMed ID: 10484076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain.
    Thiffault C; Aumont N; Quirion R; Poirier J
    J Neurochem; 1995 Dec; 65(6):2725-33. PubMed ID: 7595571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum.
    Leret ML; San Millán JA; Fabre E; Gredilla R; Barja G
    Toxicology; 2002 Jan; 170(3):165-71. PubMed ID: 11788154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats.
    Miyazaki H; Nagashima K; Okuma Y; Nomura Y
    Brain Res; 2001 Dec; 922(2):165-72. PubMed ID: 11743946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain.
    Niles LP; Sathiyapalan A; Bahna S; Kang NH; Pan Y
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1343-50. PubMed ID: 22243807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.